Accelerating the next generation of life-changing therapies

DrugBank is the intelligence operating system for biopharma, delivering the most comprehensive, structured biomedical knowledge to help advance therapies from discovery to patient impact.

Our story

DrugBank began at the University of Alberta, where co-founders Craig Knox and Michael Wilson helped create a database of 4,000 drugs and their biological targets, establishing a new standard for structured drug knowledge. Demand for this resource inspired the founders to make these essential scientific findings accessible to fuel broader industry innovation.

Today, DrugBank is the intelligence operating system built on 20+ years of curated, gold-standard biomedical knowledge. It unifies scientific and commercial intelligence while automating critical research workflows that support discovery, development, and downstream analysis.

Its mission remains rooted in powering discovery to deliver life-changing patient treatments faster.

"DrugBank has shortened the time taken to validate new drug targets by a factor of 5 to 10X"

— Head of Bioinformatics & Data Mining, Top 15 Pharma

58k+

citations in scientific publications and journals

$4B+

in global research enabled by DrugBank

9/20

top pharma companies rely on DrugBank

Meet our leadership team

Lisa Downey

CEO

Life sciences and health data executive with 20+ years of experience scaling and commercializing biomedical data platforms across real-world data, genomics, and pharma.

Mike Wilson

CPO and Co-founder

One of the world's most highly cited researchers in bioinformatics, leading product vision to turn complex science into intuitive, decision-driving tools.

Craig Knox

CTO and Co-founder

Bioinformatics expert who has architected globally recognized biomedical databases, including DrugBank and HMDB, with a focus on data quality, scale, and scientific rigor.

Advisors and board leadership

Michael Ball

Executive Chair | CEO at Marketech Solutions

Proven operator with 30+ years building, scaling, and exiting innovative start-ups and leading organizations in precision health, life sciences, genomics, and diagnostics.

Susan Roberts

Advisory Board Lead, Board Member | VP at Takeda

Experienced data, digital, and technology leader for R&D and pharmaceutical sciences, with 20+ years advancing scientific discovery and improving human health.

Dr. Andrée Bates

Advisor | Founder, CEO at Eularis

Neuroscientist with 20+ years at the intersection of clinical science, AI, and life sciences strategy, leading hundreds of AI implementations for top 20 pharma.

Mike Branson

Advisor | SVP at UCB

Life sciences and digital transformation executive with 25+ years leading biometrics, data science, and AI/ML adoption at scale across large pharma.

Backed by leading investors and funders

Keep up with the latest

EvE Bio and DrugBank Partner to Bring Record-Scale Pharmome-Mapping Data to the Drug-Discovery Community

Commercial sponsorship integrates EvE Bio's growing field-defining "pharmome" map - 385,572 rigorously confirmed drug-target interactions across 159 validated targets - into DrugBank's intelligence platform.

DrugBank Announces Leadership Transition as Company Accelerates into AI-Driven Future

As DrugBank approaches our twentieth anniversary, we are excited to announce a strategic leadership transition. This move is designed to accelerate our AI-powered innovation and lead our next phase of global growth.

Drugbank Announces Partnership With ASHP

DrugBank announced their partnership with the American Society of Health-System Pharmacists (ASHP). This move will combine both organization’s strengths at delivering reliable, trusted data and open the door for product development collaborations to address industry gaps.